Title : The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study.

Pub. Date : 2019 Sep

PMID : 31161347






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study. Metformin growth differentiation factor 15 Homo sapiens
2 AIMS/HYPOTHESIS: Growth differentiation factor 15 (GDF-15), a suggested biomarker for metformin use, may explain the potential cardioprotective and anti-cancer properties of metformin. Metformin growth differentiation factor 15 Homo sapiens
3 AIMS/HYPOTHESIS: Growth differentiation factor 15 (GDF-15), a suggested biomarker for metformin use, may explain the potential cardioprotective and anti-cancer properties of metformin. Metformin growth differentiation factor 15 Homo sapiens
4 AIMS/HYPOTHESIS: Growth differentiation factor 15 (GDF-15), a suggested biomarker for metformin use, may explain the potential cardioprotective and anti-cancer properties of metformin. Metformin growth differentiation factor 15 Homo sapiens
5 AIMS/HYPOTHESIS: Growth differentiation factor 15 (GDF-15), a suggested biomarker for metformin use, may explain the potential cardioprotective and anti-cancer properties of metformin. Metformin growth differentiation factor 15 Homo sapiens